Posted in | News

Cabot Corp Announce Plans to Close Australian Carbon Black Plant

Cabot Corporation announced today that it intends to close its carbon black manufacturing facility in Altona, Australia. This closure, which is subject to certain consultation processes, is planned to occur in early October 2005.

The decision to close the facility was driven by a number of factors including, in particular, Cabot's raw materials supplier's indication that they would cease supply in September 2005. In addition, the domestic carbon black market in Australia is in decline. The Company is in the process of debottlenecking certain of its Asia Pacific carbon black manufacturing plants in order to replace the 45,000 metric tons of production capacity in Altona.

Kennett Burnes, Cabot's Chairman and CEO stated, "This is a difficult decision and one that saddens us greatly. The Altona employees have worked very hard over the years and have operated the plant very effectively in order to support Cabot's growth in the Asia Pacific region. Unfortunately, this step is necessary as we have no viable, cost-competitive alternative for our raw material supply in Australia."

The Company expects that this closure plan will result in an estimated after-tax charge to earnings of approximately $12 million over the next two years. Net cash outlays related to the closure over this period are expected to be approximately $5 million, which include the anticipated proceeds from the sale of certain assets. The Company anticipates that because of the consolidation of production in fewer plants, the reduced operating costs will generate a payback on the Altona closure costs in less than two years.

For more information on carbon, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.